Cargando…
Pridopidine Reverses Phencyclidine-Induced Memory Impairment
Pridopidine is in clinical trials for Huntington's disease treatment. Originally developed as a dopamine D(2) receptor (D(2)R) ligand, pridopidine displays about 100-fold higher affinity for the sigma-1 receptor (sigma-1R). Interestingly, pridopidine slows disease progression and improves motor...
Autores principales: | Sahlholm, Kristoffer, Valle-León, Marta, Fernández-Dueñas, Víctor, Ciruela, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902730/ https://www.ncbi.nlm.nih.gov/pubmed/29692729 http://dx.doi.org/10.3389/fphar.2018.00338 |
Ejemplares similares
-
Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2
por: Burström, Viktor, et al.
Publicado: (2023) -
Inhibition of Tryptophan Hydroxylases and Monoamine Oxidase-A by the Proton Pump Inhibitor, Omeprazole—In Vitro and In Vivo Investigations
por: Betari, Nibal, et al.
Publicado: (2020) -
Exploring Drug-Receptor Interaction Kinetics: Lessons from a Sigma-1 Receptor Transmembrane Biosensor
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017) -
Striatal Dopamine D(2)-Muscarinic Acetylcholine M(1) Receptor–Receptor Interaction in a Model of Movement Disorders
por: Crans, René A. J., et al.
Publicado: (2020) -
Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders
por: Crans, René A. J., et al.
Publicado: (2022)